Report: Government's cancer-research network nears "a state of crisis"

04/16/2010 | Bloomberg

An analysis by the Institute of Medicine shows that 40% of Phase III clinical trials conducted by the Clinical Trials Cooperative Group Program, a unit of the National Cancer Institute, end up being terminated because of inefficiency and lack of funding. "If the clinical trial system does not improve its efficiency and effectiveness, the introduction of new treatments for cancer will be delayed and patient lives will be lost unnecessarily," according to the report.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY